Back

Acute vasoreactivity test response in postcapillary pulmonary hypertension with preserved ejection fraction. PVR level matters

13 May 2024 (11:00 - 11:45)
Organised by: Logo
Congress Presentation Part of: Myocardial disease - clinical 4 Pulmonary Hypertension HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Fabrice Bauer

University Hospitals of Paris-Sud Bicetre, Le Kremlin-Bicetre (France)

6 More presentations in this session

Presentation thumbnail
Exploring and managing pulmonary hypertension in congenital heart defects: a challenging path
Doctor J. Fernandes Pedro (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Unveiling the interplay of pulmonary hypertension parameters from right heart catheterization with cardiopulmonary exercise testing in heart failure patients
Doctor A. Ribeiro Teixeira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Unmasking exercise pulmonary hypertension - does time matter?
Doctor J. Mirinha Luz (Almada, PT)
Abstract Slides Video
Presentation thumbnail
Characteristics, outcomes, and risk stratification in obese vs. non-obese patients with pulmonary arterial hypertension
Doctor G. Savonitto (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
The unusual suspect. Is pulmonary veno-occlusive disease underrecognized?
Mr D. Ferreira (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial disease - clinical 4

The Event

Event poster

Heart Failure 2024

13 May 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
TAPSE/sPAP by echocardiography to detect elevated pulmonary vascular resistance> 4 WU in postcapillary pulmonary hypertension patients: insights from the French PH HF registry
30 August 2024
thumbnail
Congress Presentation
Acute vasoreactivity testing for severe pulmonary hypertension associated with lung disease
31 August 2024
thumbnail
Congress Presentation
The role of echodynamics for the prediction of combined pulmonary hypertension and vasoreactivity test response in advanced heart failure patients
17 May 2025
thumbnail
Congress Presentation
Walking the tightrope: judicious fluid and flow targeted therapy for acute right heart failure (RHF) in pulmonary arterial hypertension (PAH)
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources